Inhibitory effects of soluble MD-2 and soluble CD14 on bacterial growth

Microbiology and Immunology

Volumn 54, Issue 2, 2010, Pages 74-80

  Ohnishi, Takahiro ^a   Muroi, Masashi ^b   Tanamoto, Ken Ichi ^b  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b MUSASHINO UNIVERSITY   (Japan)

Author keywords

CD14; Endotoxin; MD 2

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROTEIN MD 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIABILITY; CELL VIABILITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GROWTH INHIBITION; INCUBATION TIME; NONHUMAN; PLASMID; PROTEIN PURIFICATION;

ANTIGENS, CD14; BACILLUS SUBTILIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MICROBIAL VIABILITY; PEPTIDOGLYCAN;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA;

EID: 76649143700     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2009.00186.x     Document Type: Article

References (28)

1. Visintin A., Mazzoni A., Spitzer J.A., Segal D.M. (2001) Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci U S A 98: 12156-61.
2. Schromm A.B., Lien E., Henneke P., Chow J.C., Yoshimura A., Heine H., Latz E., Monks B.G., Schwartz D.A., Miyake K., Golenbock D.T. (2001) Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J ExpMed 194: 79-88.
3. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., Kitamura T., Kosugi A., Kimoto M., Miyake K. (2002) Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3: 667-72.
4. Ohnishi T., Muroi M., Tanamoto K. (2003) MD-2 is necessary for the toll-like receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface. Clin Diagn Lab Immunol 10: 405-10.
5. Muroi M., Ohnishi T., Tanamoto K. (2002) Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B. J Biol Chem277: 42372-9.
6. Van Amersfoort E.S., Van Berkel T.J., Kuiper J. (2003) Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16: 379-414.
7. Ohnishi T., Muroi M., Tanamoto K. (2007) The lipopolysaccharide- recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2. FEMS Immunol Med Microbiol 51: 84-91.
8. da Silva Correia J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J. (2001) Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex transfer from CD14 to TLR4 and MD-2. J Biol Chem276: 21129-35.
9. Gioannini T.L., Teghanemt A., Zhang D., Coussens N.P., DockstaderW., Ramaswamy S.,Weiss J.P. (2004) Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci U S A 101: 4186-91.
10. Pugin J., Stern-Voeffray S., Daubeuf B., Matthay M.A., Elson G., Dunn-Siegrist I. (2004) Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock. Blood 104: 4071-9.
11. Landmann R., ZimmerliW., Sansano S., Link S., Hahn A., Glauser M.P., Calandra T. (1995) Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J Infect Dis 171: 639-44.
12. Landmann R., Reber A.M., Sansano S., ZimmerliW. (1996) Function of soluble CD14 in serum from patients with septic shock. J Infect Dis 173: 661-8.
13. Jia H.P., Kline J.N., Penisten A., Apicella M.A., Gioannini T.L., Weiss J., McCray P.B.J. (2004) Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. Am J Physiol Lung Cell Mol Physiol 287: L428-37.
14. Agrawal A., Suresh M.V., Singh S.K., Ferguson D.A. J. (2008) The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection. Endocr Metab Immune Disord Drug Targets 8: 231-7.
15. Levy O. (2000) A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein. Antimicrob Agents Chemother 44: 2925-31.
16. Lee J.W., Paape M.J., Elsasser T.H., Zhao X. (2003) Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli. Infect Immun 71: 4034-9.
17. Jain V., Halle A., Halmen K.A., Lien E., Charrel-Dennis M., Ram S., Golenbock D.T., Visintin A. (2008) Phagocytosis and intracellular killing of MD-2 opsonized Gram-negative bacteria depend on TLR4 signaling. Blood 2008 Jan: 18.
18. Tissieres P., Dunn-Siegrist I., Schappi M., Elson G., Comte R., Nobre V., Pugin J. (2008) Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria. Blood 111: 2122-31.
19. Labeta M.O., Vidal K., Nores J.E., Arias M., Vita N., Morgan B.P., Guillemot J.C., Loyaux D., Ferrara P., Schmid D., Affolter M., Borysiewicz L.K., Donnet-Hughes A., Schiffrin E.J. (2000) Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. J ExpMed 191: 1807-12.
20. Hirschfeld M., Ma Y.,Weis J.H., Vogel S.N.,Weis J.J. (2000) Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 165: 618-22.
21. Ohnishi T., Muroi M., Tanamoto K. (2001) N-linked glycosylations at Asn(26) and Asn(114) of human MD-2 are required for toll-like receptor 4-mediated activation of NF-kappaB by lipopolysaccharide. J Immunol 167: 3354-9.
22. Bazil V., Baudys M., Hilgert I., Stefanova I., Low M.G., Zbrozek J., Horejsi V. (1989) Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol Immunol 26: 657-62.
23. Juan T.S., Hailman E., Kelley M.J., Busse L.A., Davy E., Empig C.J., Narhi L.O.,Wright S.D., Lichenstein H.S. (1995) Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J Biol Chem270: 5219-24.
24. Iwaki D., Nishitani C., Mitsuzawa H., Hyakushima N., Sano H., Kuroki Y. (2005) The CD14 region spanning amino acids 57-64 is critical for interaction with the extracellular Toll-like receptor 2 domain. Biochem Biophys Res Commun 328: 173-6.
25. Visintin A., Latz E., Monks B.G., Espevik T., Golenbock D.T. (2003) Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J Biol Chem278: 48313-20.
26. Weidemann B., Schletter J., Dziarski R., Kusumoto S., Stelter F., Rietschel E.T., Flad H.D., Ulmer A.J. (1997) Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun 65: 858-64.
27. Dziarski R.,Wang Q., Miyake K., Kirschning C.J., Gupta D. (2001) MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. J Immunol 166: 1938-44.
28. Scherberich J.E., NockherW.A. (2000) Blood monocyte phenotypes and soluble endotoxin receptor CD14 in systemic inflammatory diseases and patients with chronic renal failure. Nephrol Dial Transplant 15: 574-8.